Alendrate

Land: New Zealand

Språk: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv ingrediens:

Alendronate sodium trihydrate 13.05mg Equivalent to 10 mg alendronic acid;  

Tilgjengelig fra:

Viatris Limited

INN (International Name):

Alendronate sodium trihydrate 13.05 mg (Equivalent to 10 mg alendronic acid)

Dosering :

10 mg

Legemiddelform:

Tablet

Sammensetning:

Active: Alendronate sodium trihydrate 13.05mg Equivalent to 10 mg alendronic acid   Excipient: Croscarmellose sodium Lactose monohydrate Magnesium stearate Microcrystalline cellulose Povidone

Enheter i pakken:

Blister pack, PVC/aluminium, 30 tablets

Klasse:

Prescription

Resept typen:

Prescription

Produsert av:

Pharmaceutical Works Polpharma SA

Indikasjoner:

Alendrate is indicated: · In postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). · In postmenopausal women who are at risk of developing osteoporosis Alendrate is indicated for the prevention of osteoporosis to reduce the risk of future fracture. · For the treatment of osteoporosis in men to prevent fractures. · For the treatment and prevention of glucocorticoid-induced osteoporosis in men, premenopausal women and postmenopausal women receiving oestrogen. · For treatment of Paget's disease of bone in men and women.

Produkt oppsummering:

Package - Contents - Shelf Life: Blister pack, PVC/aluminium - 30 tablets - 36 months from date of manufacture stored at or below 25°C

Autorisasjon dato:

2004-04-19